금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Investors Heavily Search Williams-Sonoma, Inc. (WSM): Here is What You Need to Know
Williams-Sonoma (WSM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here is What to Know Beyond Why General Motors Company (GM) is a Trending Stock
Recently, Zacks.com users have been paying close attention to General Motors (GM). This makes it worthwhile to examine what the stock has in store.
RTX Corporation (RTX) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching RTX (RTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
NextEra Energy, Inc. (NEE) is Attracting Investor Attention: Here is What You Should Know
NextEra (NEE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Nasdaq climbs to record high off the back of revived AI trade
The latest AI rally pushed the Nasdaq Composite (^IXIC) to an all-time record high above 27,200 on Tuesday. The 8:30 Hosts Julie Hyman, Jake Conley, and Pras Subramanian examine Wall Street analysis t ...
Should You Continue to Hold IDXX Stock in Your Portfolio?
IDEXX's CAG growth, expanding software adoption and global gains face headwinds from FX and weaker U.S. vet visits.
Stock Futures Slip as the Rise in Oil and Yields Restarts
Equity futures reversed gains seen earlier in premarket trading as investors grow weary of the lack of positive news on the war in Iran. Dow Jones Industrial Average futures shaved 0.3%, or 174 points ...
McDonald's puts $8.5B behind its next big comeback
Top Wealth Group sees 2X profit growth for FY26, yet stock falls
Only three consumer staples stocks have held Strong Buy ratings for at least 60 days
Alibaba in focus as Citi weighs in accelerating AI momentum, ups spending forecast
FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.